Old Web
English
Sign In
Acemap
>
authorDetail
>
Jessica Liu
Jessica Liu
Bristol-Myers Squibb
Hepatitis B
Entecavir
Virology
Lamivudine
Medicine
3
Papers
86
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Virologic, serologic, and biochemical outcomes through 2 years of treatment with entecavir and lamivudine in nucleoside-naïve Chinese patients with chronic hepatitis B: a randomized, multicenter study.
2008
Hepatology International
Guangbi Yao
Chengwei Chen
Weilun Lu
Hong Ren
Deming Tan
Yuming Wang
Daozheng Xu
Jessica Liu
Dong Xu
Cyril Llamoso
Show All
Source
Cite
Save
Citations (26)
Entecavir for the treatment of lamivudine-refractory chronic hepatitis B patients in China.
2007
Hepatology International
Guangbi Yao
Xia-Qiu Zhou
Daozheng Xu
Baoen Wang
Hong Ren
Jessica Liu
Dong Xu
Laurie MacDonald
Show All
Source
Cite
Save
Citations (14)
Efficacy and safety of entecavir compared to lamivudine in nucleoside-naïve patients with chronic hepatitis B: a randomized double-blind trial in China
2007
Hepatology International
Guangbi Yao
Chengwei Chen
Weilun Lu
Hong Ren
Deming Tan
Yuming Wang
Daozheng Xu
Zhengrong Jiang
Jessica Liu
Dong Xu
Laurie MacDonald
Show All
Source
Cite
Save
Citations (46)
1